Evidence map›Paper›PMID 28499758›Full record

ArticleThe Journal of investigative dermatology2017

Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors.

Johannes A P van de Nes, Christian Koelsche, Marco Gessi, Inga Möller, Antje Sucker, Richard A Scolyer, Michael E Buckland, Torsten Pietsch, Rajmohan Murali, Dirk Schadendorf and 1 more

Open access · greenAbstract readLetter
In one paragraph

Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Melanoma pathology: new approaches and classification.The British journal of dermatology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Atypical activation of the G protein GαThe Journal of biological chemistry · 2018
    Article
  19. NF1 mutations in conjunctival melanoma.British journal of cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Johannes A P van de NesInstitute of Pathology, Ruhr University Bochum, Bochum, Germany; Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Christian KoelscheDepartment of Neuropathology, Ruprecht-Karls-University Heidelberg, and Clinical Cooperation Unit Neuropathology, and DKTK, DKFZ, Heidelberg, Germany.
Marco GessiInstitute of Neuropathology, University of Bonn Medical Center, Bonn, Germany; Division of Histopathology, Fondazione Policlinico Universitario "A.Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Inga MöllerDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Antje SuckerDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Richard A ScolyerDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; The University of Sydney, Camperdown, NSW, Australia; Melanoma Institute Australia, North Sydney, NSW, Australia.
Michael E BucklandThe University of Sydney, Camperdown, NSW, Australia; Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Torsten PietschInstitute of Neuropathology, University of Bonn Medical Center, Bonn, Germany.
Rajmohan MuraliDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Dirk SchadendorfDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Klaus G GriewankDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany; Dermatopathologie bei Mainz, Nieder-Olm, Germany. Electronic address: klaus.griewank@uk-essen.de.
Deutschen Konsortium für Translationale Krebsforschung · DEThe University of Sydney · AUUniversity of Bonn · DEHeidelberg University · DEMemorial Sloan Kettering Cancer Center · USRuhr University Bochum · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationAdultAgedDNA Mutational AnalysisDNA, NeoplasmFemaleGenetic Predisposition to DiseaseHumansMaleMelanomaMeningeal NeoplasmsMiddle AgedPhospholipase C betaReceptors, LeukotrieneYoung Adultcysteinyl leukotriene receptor 2DNA, NeoplasmPhospholipase C betaPLCB4 protein, humanReceptors, Leukotriene

Identifiers

PMID28499758
PMCPMC5572104
OpenAlexW2613393322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.